Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 11888684)

2.
4.

Angiostatin binds ATP synthase on the surface of human endothelial cells.

Moser TL, Stack MS, Asplin I, Enghild JJ, Højrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2811-6.

5.

Angiostatin induces mitotic cell death of proliferating endothelial cells.

Hari D, Beckett MA, Sukhatme VP, Dhanabal M, Nodzenski E, Lu H, Mauceri HJ, Kufe DW, Weichselbaum RR.

Mol Cell Biol Res Commun. 2000 May;3(5):277-82.

PMID:
10964751
6.

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

Stack MS, Gately S, Bafetti LM, Enghild JJ, Soff GA.

Biochem J. 1999 May 15;340 ( Pt 1):77-84.

7.

Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.

Tuszynski GP, Sharma MR, Rothman VL, Sharma MC.

Microvasc Res. 2002 Nov;64(3):448-62.

PMID:
12453439
8.

Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.

Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y.

J Biol Chem. 2002 Sep 13;277(37):33564-70. Epub 2002 Jun 26.

10.

Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.

Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X, Kondri ME, Marti DN, Llinás M, Schaller J, Kramer RA, Trail PA.

FASEB J. 1998 Dec;12(15):1731-8.

11.

Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin.

Jiang L, Jha V, Dhanabal M, Sukhatme VP, Alper SL.

Am J Physiol Cell Physiol. 2001 May;280(5):C1140-50.

12.

Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis.

Hatziapostolou M, Katsoris P, Papadimitriou E.

Eur J Pharmacol. 2003 Jan 26;460(1):1-8.

PMID:
12535853
13.

Multiple forms of angiostatin induce apoptosis in endothelial cells.

Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS.

Blood. 1998 Dec 15;92(12):4730-41.

14.

Endothelial progenitor cells as putative targets for angiostatin.

Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T.

Cancer Res. 1999 Dec 1;59(23):5875-7.

15.

Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.

Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.

Hepatology. 2003 Mar;37(3):696-704.

PMID:
12601367
16.
17.

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.

Brauer R, Beck IM, Roderfeld M, Roeb E, Sedlacek R.

BMC Biochem. 2011 Jul 25;12:38. doi: 10.1186/1471-2091-12-38.

18.
19.

Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.

Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6656-61. Epub 2001 May 29.

20.

Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide.

Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, Chilian WM.

Circulation. 2002 May 7;105(18):2185-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk